Zogenix Inc Revenue per Employee (ZGNX), current and historic results, rankings and more, quarterly fundamentals - CSIMarket
CSIMarket
 


Zogenix Inc   (NASDAQ: ZGNX)
 

Zogenix Inc 's Revenue per Employee

Quarterly Results, Trends, Rankings, Statistics, Cumulative Sales


With a revenue increase of 212.95% in the fourth quarter 2021, year on year to cumulative value of $82 million, Zogenix Inc 's revenue per employee grew on a trailing twelve months basis to $ 3,848, this marks a new company high.
Within the Healthcare sector Employees of 364 other companies have achieved higher revenue per employee. While Zogenix Inc 's total ranking has deteriorated compared to the previous quarter from 0 to 3199. Zogenix Inc has 21,230 employees.


What is Sales per Employee Ratio?







ZGNX Revenue per Employee (Dec 31 2021)
IV. Quarter
(Sep 30 2021)
III. Quarter
(Jun 30 2021)
II. Quarter
(Mar 31 2021)
I. Quarter
(Dec 31 2020)
IV. Quarter
Y / Y Revenue Change 212.95 % 690.56 % 1720.64 % 1157.72 % 336.22 %
Sales per Employee (TTM) $ 3,848 2,995 2,065 1,228 635
ZGNX's Total Ranking # 3199 # 0 # 0 # 0 #
Seq. Revenue Change 17.68 % 20.34 % 37.31 % 60.95 % 197.27 %


Revenue per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 152
Healthcare Sector # 365
Overall Market # 3199

Revenue per Employee Statistics
High Average Low
$ 3,848 $ 1,207 $ 0
(Dec 31 2021)   (Sep 30 2020)



Financial Statements
Zogenix Inc 's Revenue MRQ $ 27 Millions Visit ZGNX's Income Statement
Zogenix Inc 's Revenues TTM $ 82 Millions Visit ZGNX's aggregate revenue growth
What are ZGNX's Sales? Visit ZGNX's Sales by Segment




Other Ratios
Zogenix Inc 's Income per Employee
Employees in Major Pharmaceutical Preparations
Major Pharmaceutical Preparations Industry Revenue per Employee Trends and Statistics
Healthcare Sector Revenue per Employee Statistics
Revenue per Employee Trends for overall market
ZGNX's Revenue per Employee versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue per Employee
Lowest Ranking Revenue per Employee
Revenue per Employee for ZGNX's Competitors
Revenue per Employee for ZGNX's Suppliers
Revenue per Employee for ZGNX's Customers

You may also want to know
ZGNX's Sales Growth Rates ZGNX's Pe Price to earnings ratio ZGNX's Receivables Turnover Ratio ZGNX's Stock Quote
ZGNX's Net Income Growth Rates ZGNX's Ps Price to Sales ratio ZGNX's Sales per Employee ZGNX's Asset Turnover Ratio
ZGNX's Net Margin ZGNX's Pb Price to Book ratio ZGNX's Financial Strength Ratios ZGNX's Dividend Payout Ratio
Date modified: 2026-09-08T15:10:30+00:00




Companies with similar Revenue per Employee for 12 months ending Dec 31 2021, within Healthcare Sector Revenue per Employee Revenue 12 months ending Dec 31 2021Number of Employees Dec 31 2021
Aim Immunotech Inc   6,428.57 $ 0.135  Million 21 
Geron Corporation  5,399.22 $ 1.393  Million 258 
Sunshine Biopharma Inc   4,568.52 $ 0.228  Million 50 
Nano X Imaging Ltd  4,390.57 $ 1.304  Million 297 
Xtl Biopharmaceuticals Ltd   4,200.00 $ 0.021  Million
Lexicon Pharmaceuticals Inc   3,679.01 $ 0.298  Million 81 
Tff Pharmaceuticals Inc  3,526.44 $ 0.088  Million 25 
Biorestorative Therapies Inc   3,285.71 $ 0.046  Million 14 
Petvivo Holdings Inc   2,972.77 $ 0.065  Million 22 
Quantum Cyber N v   2,858.16 $ 0.577  Million 202 
Biocorrx Inc   2,681.78 $ 0.048  Million 18 
Altamira Therapeutics Ltd   2,183.59 $ 0.070  Million 32 




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.